These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 8441835)

  • 1. Effect of oxypurinol on renal reperfusion injury in the rat.
    Dillon JJ; Grossman SH; Finn WF
    Ren Fail; 1993; 15(1):37-45. PubMed ID: 8441835
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oxygen free radicals in ischemic acute renal failure in the rat.
    Paller MS; Hoidal JR; Ferris TF
    J Clin Invest; 1984 Oct; 74(4):1156-64. PubMed ID: 6434591
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An evaluation of antioxidant effects on recovery from postischemic acute renal failure.
    Zager RA; Fuerstenberg SM; Baehr PH; Myerson D; Torok-Storb B
    J Am Soc Nephrol; 1994 Feb; 4(8):1588-97. PubMed ID: 7912960
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oxypurinol-enhanced postischemic recovery of the rat brain involves preservation of adenine nucleotides.
    Phillis JW; Perkins LM; Smith-Barbour M; O'Regan MH
    J Neurochem; 1995 May; 64(5):2177-84. PubMed ID: 7722503
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Xanthine oxidase inhibition does not limit canine infarct size.
    Werns SW; Grum CM; Ventura A; Hahn RA; Ho PP; Towner RD; Fantone JC; Schork MA; Lucchesi BR
    Circulation; 1991 Mar; 83(3):995-1005. PubMed ID: 1999047
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of xanthine oxidase in reperfusion injury of ischemic skeletal muscles in the pig and human.
    Dorion D; Zhong A; Chiu C; Forrest CR; Boyd B; Pang CY
    J Appl Physiol (1985); 1993 Jul; 75(1):246-55. PubMed ID: 8397177
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of xanthine oxidase inhibition on ischemic acute renal failure in the rat.
    Zager RA; Gmur DJ
    Am J Physiol; 1989 Dec; 257(6 Pt 2):F953-8. PubMed ID: 2603962
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The pharmacokinetics of injectable allopurinol in newborns with the hypoplastic left heart syndrome.
    McGaurn SP; Davis LE; Krawczeniuk MM; Murphy JD; Jacobs ML; Norwood WI; Clancy RR
    Pediatrics; 1994 Dec; 94(6 Pt 1):820-3. PubMed ID: 7970996
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The xanthine oxidase inhibitor oxypurinol does not limit infarct size in a canine model of 40 minutes of ischemia with reperfusion.
    Kinsman JM; Murry CE; Richard VJ; Jennings RB; Reimer KA
    J Am Coll Cardiol; 1988 Jul; 12(1):209-17. PubMed ID: 3379207
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Concentrations of adenosine and its metabolites in the rat retina/choroid during reperfusion after ischemia.
    Roth S; Park SS; Sikorski CW; Osinski J; Chan R; Loomis K
    Curr Eye Res; 1997 Sep; 16(9):875-85. PubMed ID: 9288448
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes in the xanthine dehydrogenase/xanthine oxidase ratio in the rat kidney subjected to ischemia-reperfusion stress: preventive effect of some flavonoids.
    Sanhueza J; Valdes J; Campos R; Garrido A; Valenzuela A
    Res Commun Chem Pathol Pharmacol; 1992 Nov; 78(2):211-8. PubMed ID: 1475527
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oxygen free radical induced damage in kidneys subjected to warm ischemia and reperfusion. Protective effect of superoxide dismutase.
    Baker GL; Corry RJ; Autor AP
    Ann Surg; 1985 Nov; 202(5):628-41. PubMed ID: 3840348
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetic/Pharmacodynamic Modelling of Allopurinol, its Active Metabolite Oxypurinol, and Biomarkers Hypoxanthine, Xanthine and Uric Acid in Hypoxic-Ischemic Encephalopathy Neonates.
    Chu WY; Annink KV; Nijstad AL; Maiwald CA; Schroth M; Bakkali LE; van Bel F; Benders MJNL; van Weissenbruch MM; Hagen A; Franz AR; Dorlo TPC; Allegaert K; Huitema ADR;
    Clin Pharmacokinet; 2022 Feb; 61(2):321-333. PubMed ID: 34617261
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beneficial effects of oxypurinol pretreatment in stunned, reperfused canine myocardium.
    Holzgrefe HH; Gibson JK
    Cardiovasc Res; 1989 Apr; 23(4):340-50. PubMed ID: 2590915
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effectiveness of postischemic oxypurinol administration upon myocardial function in the isolated rat heart.
    Badylak SF; Voorhees WD; Babbs CF; Simmons A
    Resuscitation; 1988 Jan; 16(1):31-43. PubMed ID: 2831601
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Allopurinol or oxypurinol in heart failure therapy - a promising new development or end of story?
    Reyes AJ; Leary WP
    Cardiovasc Drugs Ther; 2005 Oct; 19(5):311-3. PubMed ID: 16382292
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of xanthine oxidase inhibitors on the prognosis of acute intestinal ischemia].
    Holgado Madruga M; Refoyo Enríquez A; Mariño Hernández E; Martín Rollán C; García García J; Macías Núñez JF
    An Med Interna; 1989 Apr; 6(4):177-82. PubMed ID: 2562372
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oxypurinol attenuates hydroxyl radical production during ischemia/reperfusion injury of the rat cerebral cortex: an ESR study.
    Phillis JW; Sen S
    Brain Res; 1993 Nov; 628(1-2):309-12. PubMed ID: 8313161
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discrepancy between biochemical normalization and morphological recovery of jejunal mucosa during postischemic reperfusion in presence of the xanthine oxidase inhibitor oxypurinol.
    Siems W; Kowalewski J; David H; Grune T; Bimmler M
    Cell Mol Biol; 1991; 37(2):213-26. PubMed ID: 1878927
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does xanthine oxidase contribute to the hydroxyl radical generation in ischemia and reperfusion of the cochlea?
    Tabuchi K; Tsuji S; Ito Z; Hara A; Kusakari J
    Hear Res; 2001 Mar; 153(1-2):1-6. PubMed ID: 11223291
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.